1. Home
  2. IMMP vs ALDF Comparison

IMMP vs ALDF Comparison

Compare IMMP & ALDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • ALDF
  • Stock Information
  • Founded
  • IMMP 1987
  • ALDF 2024
  • Country
  • IMMP Australia
  • ALDF United States
  • Employees
  • IMMP N/A
  • ALDF N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • ALDF
  • Sector
  • IMMP Health Care
  • ALDF
  • Exchange
  • IMMP Nasdaq
  • ALDF NYSE
  • Market Cap
  • IMMP 221.2M
  • ALDF 313.9M
  • IPO Year
  • IMMP N/A
  • ALDF 2024
  • Fundamental
  • Price
  • IMMP $1.64
  • ALDF $10.51
  • Analyst Decision
  • IMMP Buy
  • ALDF
  • Analyst Count
  • IMMP 1
  • ALDF 0
  • Target Price
  • IMMP $7.00
  • ALDF N/A
  • AVG Volume (30 Days)
  • IMMP 105.9K
  • ALDF 63.5K
  • Earning Date
  • IMMP 02-27-2025
  • ALDF 01-01-0001
  • Dividend Yield
  • IMMP N/A
  • ALDF N/A
  • EPS Growth
  • IMMP N/A
  • ALDF N/A
  • EPS
  • IMMP N/A
  • ALDF N/A
  • Revenue
  • IMMP $3,019,249.00
  • ALDF N/A
  • Revenue This Year
  • IMMP $50.37
  • ALDF N/A
  • Revenue Next Year
  • IMMP N/A
  • ALDF N/A
  • P/E Ratio
  • IMMP N/A
  • ALDF $100.51
  • Revenue Growth
  • IMMP 24.11
  • ALDF N/A
  • 52 Week Low
  • IMMP $1.32
  • ALDF $9.90
  • 52 Week High
  • IMMP $2.72
  • ALDF $10.69
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 42.47
  • ALDF N/A
  • Support Level
  • IMMP $1.53
  • ALDF N/A
  • Resistance Level
  • IMMP $1.67
  • ALDF N/A
  • Average True Range (ATR)
  • IMMP 0.07
  • ALDF 0.00
  • MACD
  • IMMP -0.01
  • ALDF 0.00
  • Stochastic Oscillator
  • IMMP 30.49
  • ALDF 0.00

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About ALDF ALDEL FINL II INC

Aldel Financial II Inc is a Shell Company with various businesses.

Share on Social Networks: